|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| G01N 33/53 | |||
| C07K 16/24 |
| (11) | Patento numeris | 2332575 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10179775.1 |
| Europos patento paraiškos padavimo data | 2004-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 532130 P | 2003-12-23 | US |
| (72) |
Fung, Sek Chung, US
Moyle, Matthew, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | Treatment of cancer with novel anti-IL 13 monoclonal antibodies |
| Treatment of cancer with novel anti-IL 13 monoclonal antibodies |